Company Data
AN2 Therapeutics Inc.
Ticker
ANTX
Current Price
$1.2 -4%
Market Cap
$32.9M
Price Target
Refer to Report
Volume
21.9K
52wk Range
$1 - $1.55
Overview
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.